New Kids' flu drug enters final testing phase
NCT ID NCT07357051
Summary
This study is testing a new oral medicine called JKN2301 to treat the flu in children aged 2 to 11 years. It will compare the new medicine's safety and how well it works against an existing flu treatment. Researchers will measure how quickly children feel better and how long the virus stays in their system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY VIRAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.